Target intelligence / Profile preview

Invertebrate glutamate-gated chloride channel receptor (GluCl)

Target
GluCl
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor family
01

Overview

The invertebrate glutamate-gated chloride channel receptor (GluCl) is a member of the Cys-loop family of ligand-gated ion channels, found exclusively in protostome invertebrates such as nematodes and arthropods (Wolstenholme, 2012, PubMed: 22512310). These receptors mediate fast inhibitory neurotransmission by facilitating the influx of chloride ions into neurons and muscle cells upon binding the neurotransmitter L-glutamate, resulting in membrane hyperpolarization (Cully et al., 1994, Nature: 371(6499)). GluCls play vital roles in regulating locomotion, feeding, and sensory input in parasites. They are the primary molecular targets for the macrocyclic lactone class of antiparasitic drugs, including ivermectin and moxidectin (Hibbs & Gouaux, 2011, Nature: 474(7349)). These drugs act as potent allosteric agonists, locking the channel in an open state, which leads to flaccid paralysis and the eventual death or expulsion of the parasite from the host. Because GluCls are absent in vertebrate genomes, these drugs typically exhibit a high margin of safety for the host. However, neurotoxicity can occur in hosts with compromised blood-brain barriers or specific genetic mutations in efflux transporters like MDR1 (Mealey et al., 2001, Pharmacogenetics: 11(8)).

Other names
Glutamate-gated chloride channelGluClRAvermectin-sensitive glutamate-gated chloride channel
02

Mechanism of action

Positive allosteric modulation and activation of the channel, leading to increased chloride conductance, membrane hyperpolarization, and flaccid paralysis of the parasite (Hibbs & Gouaux, 2011, Nature).

03

Biological functions

Inhibitory neurotransmissionLocomotionFeeding behaviorSensory processing
04

Disease associations

HelminthiasisEctoparasitic infestationInfection
05

Safety considerations

Neurotoxicity in hosts with ABCB1 (MDR1) gene mutations (e.g., Collies) due to blood-brain barrier permeabilityEmergence of anthelmintic resistance in parasite populationsPotential off-target activity at vertebrate GABA-A or glycine receptors at high concentrations
06

Interacting drugs

Ivermectin

6 more in the full profile.

07

Biomarkers

Fecal egg count reduction test (FECRT)Microfilarial densityLarval development assay (LDA)Parasite motility inhibition

Beyond the preview

Go deeper on Invertebrate glutamate-gated chloride channel receptor (GluCl).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invertebrate glutamate-gated chloride channel receptor (GluCl).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call